Biotech stocks rallied after a government report said that Medicare cost-cutting measures will not be triggered this year.
Jim Cramer saw a room for opportunity with one stock that wasn't supposed to drop.
The "Fast Money" traders weighed election risks for biotech after Obama officially endorsed Hillary Clinton.
The "Fast Money" traders give you 4 trades in biotech leading up to this year's controversial election.
"Halftime Report" trader Jon Najarian bought Gilead and Weatherford for his CNBC PRO model portfolio, which is currently up 13 percent on the year.
"FMHR" trader Jon Najarian makes some trades in his Halftime Portfolio including Gilead Sciences and Weatherford International.
The "FMHR" traders discuss the biotech and pharmaceuticals trade and give their best bets for stocks.
New data from eVestment shows that Facebook stock is now ranked 14th among institutional holders.
History shows this is pretty much the "worst thing" you can do, according to value investing legend Joel Greenblatt.
Jim Cramer rattles off his take on caller favorite stocks, including this bank stock that has been blessed by the Oracle of Omaha.
CNBC's Meg Tirrell reports on the companies that are working to fight the Zika virus.
Jim Cramer is finally stumped by a stock. He provides his take on various caller favorite stocks in the lightning round.
Amid the wreckage in the retail sector, is now the time to cherry-pick some of the names that may have been unfairly punished?
U.S. stocks closed lower, under pressure from disappointing Disney and Macy's earnings, amid sharp gains in oil following a surprise inventory draw.
John Buckingham, AFAM Capital CIO, and Kevin Mahn, Hennion & Walsh Asset Management President & CIO, talk about the current state of the markets and give their picks.
David Katz, Matrix Asset Advisors shares his platinum portfolio trades in energy, and technology.
Biotech stocks dragged on the market Friday, and some "Fast Money" traders contended the pain may not be done.
Gilead Sciences fell nearly 8 percent, dragging down the S&P 500’s health care sector.
The "Fast Money" traders get into biotech and give you 5 trades in a mixed sector.
U.S. stocks closed lower as health care stocks weighed, but the major averages pared losses significantly for the Dow and S&P to post monthly gains.